Eculizumab Seems to be a Life Saver Even in Shiga Toxin-Related Hemolytic-Uremic Syndrome
- PMID: 38427451
- PMCID: PMC10962861
- DOI: 10.1681/ASN.0000000000000283
Eculizumab Seems to be a Life Saver Even in Shiga Toxin-Related Hemolytic-Uremic Syndrome
Conflict of interest statement
The author has nothing to disclose.
Comment in
-
Authors' Reply: Eculizumab Seems to be a Life Saver Even in Shiga Toxin-Related Hemolytic Uremic Syndrome.J Am Soc Nephrol. 2024 Mar 1;35(3):385. doi: 10.1681/ASN.0000000000000282. J Am Soc Nephrol. 2024. PMID: 38427452 Free PMC article. No abstract available.
Comment on
-
Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.J Am Soc Nephrol. 2023 Sep 1;34(9):1561-1573. doi: 10.1681/ASN.0000000000000182. Epub 2023 Jun 12. J Am Soc Nephrol. 2023. PMID: 37303085 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
